CHO Plus is creating regulatory compliant genetically engineered mammalian cells to be used by biopharmaceutical companies for therapeutic protein manufacturing. Early proof of concept experiments demonstrate CHO Plus cells to be 4.5-fold more productive than parent cells in model system. The CHO Plus approach includes patented methods for genetically engineering mammalian cells; proprietary and patented targeted transfection technology; and efficient clone screening technology.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 329 Oyster Point Blvd, South San Francisco,california 94080,united States
- in****@****lus.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cho-plus.com
- HQ
- South San Francisco, California
Cho Plus, Inc. Questions
Cho Plus, Inc.'s website is cho-plus.com
Cho Plus, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cho-plus
Cho Plus, Inc. has
12 employees.
View email and phone details for 12
employees at Cho Plus, Inc..
Cho Plus, Inc.'s industry is
Biotechnology Research
Cho Plus, Inc.'s top competitors are
Avenue Biosciences,
Nanovery,
Amptiv Biosciences,
Centivax,
Chemt Biotechnology,
Inso Biosciences,
Brightest Bio,
Osem Fluidics,
Amplified Sciences, Inc.,
Full Circles Therapeutics Inc..
Cho Plus, Inc.'s support email address is info@CHO-Plus.com
Cho Plus, Inc.'s categories are Biotechnology Research
Cho Plus, Inc.'s founding year is 2014
